Effect of implant dose/volume and surgical resection on survival in a rat glioma brachytherapy model: Implications for brain tumor therapy

被引:6
作者
Bampoe, J
Glen, J
Mackenzie, I
Porter, P
Bernstein, M
机构
[1] UNIV TORONTO, TORONTO HOSP, TORONTO WESTERN DIV, DIV NEUROSURG, TORONTO, ON M5T 2S8, CANADA
[2] UNIV TORONTO, TORONTO HOSP, DIV NEUROPATHOL, TORONTO, ON M5T 2S8, CANADA
关键词
brachytherapy; rat brain tumor model; surgery; survival times;
D O I
10.1097/00006123-199712000-00026
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE: This study sought to investigate the effects of implant dose/volume and surgical resection on survival in a rat glioma brachytherapy model, Two doses were investigated to determine a suitable therapeutic range, METHODS: We performed two experiments. Three treatment groups and one control group of male F-344 rats bearing 9L brain tumors 12 days after tumor inoculation were used in the first experiment. Day 12 tumors were an average of 4 to 6 mm in diameter. Animals treated with brachytherapy received a tumor dose of 80 Gy delivered to a 5.5-mm-radius volume. Total macroscopic tumor removal was achieved by microsurgical techniques. A subsequent experiment compared the survival of tumor-burdened rats treated with an implant dose of 60 Gy delivered to a 5.5-mm-radius volume with a control group. RESULTS: Surgery alone produced an increased life span of 28.6% over control animals treated with sham surgery and dummy seed implants, a statistically significant increase in survival (P = 0.0023, log-rank test), Brachytherapy alone produced the most significant increase in survival over control animals (P = 0.0001, log-rank test; median survival not attained with an implant dose of 80 Gy delivered to a 5.5-mm-radius volume; and P = 0.0001, increased life span 121% with an implant dose of 60 Gy delivered to a 5.5-mm-radius volume). This was not improved by the addition of surgical tumor removal. CONCLUSION: We have demonstrated a relationship between implant dose/volume and survival of tumor-burdened rats in this model that is not improved by the addition of tumor removal. Implications for brain tumor brachytherapy are discussed.
引用
收藏
页码:1374 / 1383
页数:10
相关论文
共 50 条
[11]  
DETRIBOLET N, 1992, NEUROSURGERY SCI BAS, P585
[12]  
FIKE JR, 1985, NEUROSURGERY, V16, P530
[13]  
GREEN SB, 1994, BRAIN TUMOR COOPERAT, P174
[14]   THE EFFECT OF I-125 INTERSTITIAL RADIOTHERAPY ON BLOOD-BRAIN-BARRIER FUNCTION IN NORMAL CANINE BRAIN [J].
GROOTHUIS, DR ;
WRIGHT, DC ;
OSTERTAG, CB .
JOURNAL OF NEUROSURGERY, 1987, 67 (06) :895-902
[15]   EXTERNAL IRRADIATION FOLLOWED BY AN INTERSTITIAL HIGH-ACTIVITY I-125 IMPLANT BOOST IN THE INITIAL TREATMENT OF MALIGNANT GLIOMAS - NCOG STUDY 6G-82-2 [J].
GUTIN, PH ;
PRADOS, MD ;
PHILLIPS, TL ;
WARA, WM ;
LARSON, DA ;
LEIBEL, SA ;
SNEED, PK ;
LEVIN, VA ;
WEAVER, KA ;
SILVER, P ;
LAMBORN, K ;
LAMB, S ;
HAM, B .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (03) :601-606
[16]   COMBINATION THERAPY WITH 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA AND LOW-DOSE RATE RADIATION IN THE 9L RAT-BRAIN TUMOR AND SPHEROID MODELS - IMPLICATIONS FOR BRAIN-TUMOR BRACHYTHERAPY [J].
GUTIN, PH ;
BERNSTEIN, M ;
SANO, Y ;
DEEN, DF .
NEUROSURGERY, 1984, 15 (06) :781-786
[17]   RECURRENT MALIGNANT GLIOMAS - SURVIVAL FOLLOWING INTERSTITIAL BRACHYTHERAPY WITH HIGH-ACTIVITY I-125 SOURCES [J].
GUTIN, PH ;
LEIBEL, SA ;
WARA, WM ;
CHOUCAIR, A ;
LEVIN, VA ;
PHILIPS, TL ;
SILVER, P ;
DASILVA, V ;
EDWARDS, MSB ;
DAVIS, RL ;
WEAVER, KA ;
LAMB, S .
JOURNAL OF NEUROSURGERY, 1987, 67 (06) :864-873
[18]   ASSUMPTIONS IN THE RADIOTHERAPY OF GLIOBLASTOMA [J].
HOCHBERG, FH ;
PRUITT, A .
NEUROLOGY, 1980, 30 (09) :907-911
[19]  
Hoshino T, 1977, Natl Cancer Inst Monogr, V46, P29
[20]   REVIEW OF BASIC CONCEPTS OF CELL-KINETICS AS APPLIED TO BRAIN TUMORS [J].
HOSHINO, T ;
WILSON, CB .
JOURNAL OF NEUROSURGERY, 1975, 42 (02) :123-131